Dehydroepiandrosterone treatment in the aging male - What should the urologist know?

European Urology

Volumn 48, Issue 5, 2005, Pages 724-733

  Saad, F ^a   Hoesl, C E ^b   Oettel, M ^b   Fauteck, J D ^c   Rommler A ^b  

^a GULF MEDICAL UNIVERSITY   (United Arab Emirates)

^b Proverum GmbH ^*  (Germany)

^c Proverum GmbH   (Germany)

Author keywords

Adrenopause; Aging; Androgen deficiency; Dehydroepiandrosterone; DHEA

Indexed keywords

INSULIN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; PRASTERONE; SOMATOMEDIN BINDING PROTEIN;

ACNE; ALZHEIMER DISEASE; ANDROGEN DEFICIENCY; ANDROGEN SYNTHESIS; AREA UNDER THE CURVE; BODY COMPOSITION; BONE DENSITY; CARDIOVASCULAR SYSTEM; CELL AGING; EDEMA; ERECTILE DYSFUNCTION; GYNECOMASTIA; HAMILTON SCALE; HEART ARRHYTHMIA; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNE RESPONSE; IMPOTENCE; INSULIN SENSITIVITY; MALE TYPE ALOPECIA; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; MEDLINE; METABOLIC SYNDROME X; NERVOUSNESS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PSYCHOMETRY; RATING SCALE; REVIEW; SEXUAL FUNCTION; SIDE EFFECT; SLEEP DISORDER; SYSTEMIC LUPUS ERYTHEMATOSUS; WEIGHT GAIN;

AGING; CARDIOVASCULAR PHYSIOLOGY; CLINICAL TRIALS; DEHYDROEPIANDROSTERONE; DIETARY SUPPLEMENTS; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; PENILE ERECTION;

EID: 27144453742     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.06.020     Document Type: Review

References (93)

1. S.S.C. Yen Adrenal Andropause and Aging J Anti-Aging Med 3 2000 315 328
2. N. Orentreich, J.L. Brind, R.L. Rizer, and J.H. Vogelman Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood J Clin Endocrinol Metab 59 1984 551 555
3. S. Kiechl, J. Willeit, E. Bonora, S. Schwarz, and Q. Xu No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck Study) Arterioscler Thromb Vasc Biol 20 2000 1094 1100
4. S. Legrain, C. Massien, N. Lahlou, M. Roger, B. Debuire, and B. Diquet Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects J Clin Endocrinol Metab 85 2000 3208 3217
5. F. Labrie, A. Bélanger, L. Cusan, and B. Candas Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology J Clin Endocrinol Metab 82 1997 2403 2409
6. D. Liu, and J.S. Dillon Dehydroepiandrosterone activates endothelial cell nitric oxide synthase by a specific plasma membrane receptor coupled to Gα(i2,3) J Biol Chem 277 2002 21379 21388
7. E.E. Baulieu, and P. Robel Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids Proc Natl Acad Sci USA 95 1998 4089 4091
8. G.S. Roth, M.A. Lane, D.K. Ingram, J.A. Mattison, D. Elahi, and J.D. Tobin Biomarkers of Caloric Restriction May Predict Longevity in Humans Science 297 2002 811
9. E. Barrett-Connor, and S.L. Edelstein A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: The Rancho Bernardo Study J Am Geriatr Soc 42 1994 420 423
10. C. Schulman, and B. Lunenfeld The ageing male World J Urol 20 2002 4 10
11. H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, and J.B. McKinlay Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study J Urol 151 1994 54 61
12. W.J. Reiter, A. Pycha, G. Schatzl, H.C. Klingler, I. Mark, and A. Auterith Serum dehydroepiandrosterone sulfate concentrations in men with erectile dysfunction Urology 55 2000 755 758
13. O. Alexopoulou, J. Jamart, D. Maiter, M.P. Hermans, R. De Hertogh, and P. De Nayer Erectile dysfunction and lower androgenicity in type 1 diabetic patients Diabetes Metab 27 2001 329 336
14. W.J. Reiter, A. Pycha, G. Schatzl, A. Pokorny, D.M. Gruber, and J.C. Huber Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study Urology 53 1999 590 594
15. S. Arver, A.S. Dobs, A.W. Meikle, R.P. Allen, S.W. Sanders, and N.A. Mazer Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system J Urol 155 1996 1604 1608
16. W. Arlt, F. Callies, J.C. van Vlijmen, I. Koehler, M. Reincke, and M. Bidlingmaier Dehydroepiandrosterone replacement in women with adrenal insufficiency N Engl J Med 341 1999 1013 1020
17. A.D. Genazzani, M. Stomati, F. Bernardi, M. Pieri, L. Rovati, and A.R. Genazzani Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids Fertil Steril 80 2003 1495 1501
18. G. Johannsson, P. Burman, L. Wiren, B.E. Engstrom, A.G. Nilsson, and M. Ottosson Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial J Clin Endocrinol Metab 87 2002 2046 2052
19. F. Labrie, P. Diamond, L. Cusan, J.L. Gomez, A. Belanger, and B. Candas Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women J Clin Endocrinol Metab 82 1997 3498 3505
20. H. Kawano, H. Yasue, A. Kitagawa, N. Hirai, T. Yoshida, and H. Soejima Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men J Clin Endocrinol Metab 88 2003 3190 3195
21. W.J. Reiter, G. Schatzl, I. Mark, A. Zeiner, A. Pycha, and M. Marberger Dehydroepiandrosterone in the treatment of erectile dysfunction in patients with different organic etiologies Urol Res 29 2001 278 281
22. A. Römmler Adrenopause and dehydroepiandrosterone: Pharmacological therapy versus replacement therapy Gynaekol Geburtshilfl Rundsch 43 2003 79 90
23. E.E. Baulieu, G. Thomas, S. Legrain, N. Lahlou, M. Roger, and B. Debuire Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge study to a sociobiomedical issue Proc Nat Acad Sci 97 2000 4279 4284
24. A.R. Genazzani, S. Inglese, I. Lombardi, M. Pieri, F. Bernardi, and A.D. Genazzani Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency Aging Male 7 2004 133 143
25. M. Algarté-Génin, O. Cussenot, and P. Costa Prevention of prostate cancer by androgens: experimental paradox or clinical reality Eur Urol 46 2004 285 294
26. J.R.D.C.I. Matias, V. Malloy, and N. Orentreich Inhibition of prostate cancer in rats by the administration of dehydroepiandrosterone Ann NY Acad Sci 453 1987 316 328
27. K.V. Rao, W.D. Johnson, M.C. Bosland, R.A. Lubet, V.E. Steele, and G.J. Kelloff Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone Cancer Res 59 1999 3084 3089
28. C. Voermans, M.S. Condon, and M.C. Bosland Growth inhibition by dehydroepiandrosterone of human prostate cancer cell lines and primary epithelial cultures of rat prostate carcinomas Proc Annu Meet Am Assoc Cancer Res 37 1996 1933
29. J.T. Arnold, H. Le, K.K. McFann, and M.R. Blackman Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells Am J Physiol Endocrinol Metab 288 2005 E573 E584
30. F. Stahl, D. Schnorr, C. Pilz, and G. Dorner Dehydroepiandrosterone (DHEA) levels in patients with prostatic cancer, heart diseases and under surgery stress Exp Clin Endocrinol 99 2 1992 68 70
31. G.W. Comstock, G.B. Gordon, and A.W. Hsing The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate Cancer Epidemiol Biomarkers Prev 2 1993 219 221
32. P. Lagiou, C.S. Mantzoros, A. Tzonou, L.B. Signorello, L. Lipworth, and D. Trichopoulos Serum steroids in relation to benign prostatic hyperplasia Oncology 54 1997 497 501
33. M. Muller, Y.T. van der Schouw, J.H.H. Thijssen, and D.E. Grobbee Cardiovascular Endocrinology. Endogenous Sex Hormones and Cardiovascular Disease in Men J Clin Endocrinol Metab 88 2003 5076 5086
34. I. Poršová-Dutoit, J. Šulcová, and L. Stárka Do DHEA/DHEAS play a protective role in coronary heart disease? Physiol Res 49 Suppl 1 2000 S43 S56
35. M. Adamkiewicz, S. Zgliczyński, J. Słowińska- Srzednicka, W. Jeske, M. Rabijewski, and E. Pietrzyk The relationship between plasma androgens (dehydroepiandrosterone sulfate and testosterone), insulin, coagulation and fibrinolytic factors in men with coronary arteriosclerosis Aging Male 1 1998 270 279
36. F. Ishihara, K. Hiramatsu, S. Shigematsu, T. Aizawa, A. Niwa, and N. Takasu Role of adrenal androgens in the development of ateriosclerosis as judged by pulse wave velocity and calcification of the aorta Cardiology 80 1992 332 338
37. A. Tchernof, and F. Labrie Dehydroepiandrosterone, obesity and cardiovascular disease: a review of human studies Eur J Endocrinol 151 2004 1 14
38. F. Callies, M. Fassnacht, J.C. van Vlijmen, I. Koehler, D. Huebler, and M.J. Seibel Dehydroepiandrosterone replacement in women with adrenal insufficiency: Effects on body composition, serum leptin, bone turnover, and exercise capacity J Clin Endocrinol Metab 86 2001 1968 1972
39. M.A. Flynn, D. Weaver-Osterholtz, K.L. Sharpe-Timms, S. Allen, and G. Krause Dehydroepiandrosterone replacement in aging humans J Clin Endocrinol Metab 84 1999 1527 1533
40. D. Jedrzejuk, M. Medras, A. Milewicz, and M. Demissie Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism Aging Male 6 2003 151 156
41. A.J. Morales, R.H. Haubrich, J.Y. Hwang, H. Asakura, and S.S.C. Yen The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women Clin Endocrinol 49 1998 421 432
42. D.T. Villareal, J.O. Holloszy, and W.M. Kohrt Effects of DHEA replacement on bone mineral density and body composition in elderly women and men Clin Endocrinol 53 2000 561 568
43. D.T. Villareal, and J.O. Holloszy Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial JAMA 292 2004 2243 2248
44. M. Suzuki, A. Kanazawa, M. Hasegawa, Y. Hattori, and Y. Harano A close association between insulin resistance and dehydroepiandrosterone sulfate in subjects with essential hypertension Endocrine J 46 1999 521 528
45. R. Mottl, and J. Cerman A relationship between dehydroepiandrosterone sulphate and insulin resistance in obese men and women Vnitr Lek 50 2004 923 929
46. Y. Sun, M. Mao, L. Sun, Y. Feng, J. Yang, and P. Shen Treatment of osteoporosis in men using dehydroepiandrosterone sulfate Chin Med J 115 2002 402 404
47. R. Takayanagi, K. Goto, S. Suzuki, S. Tanaka, S. Shimoda, and H. Nawata Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts Mech Ageing Dev 123 2002 1107 1114
48. N. Ohmori, K. Nomura, K. Ohmori, Y. Kato, T. Itoh, and K. Takano Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome Endocr J 50 2003 1 7
49. M. Minetto, G. Reimondo, G. Osella, M. Ventura, A. Angeli, and M. Terzolo Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome Osteoporosis Int 15 2004 855 861
50. A.J. Morales, J.J. Nolan, J.C. Nelson, and SS.C. Yen Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age J Clin Endocrinol Metab 78 1994 1360 1367
51. E.E. Baulieu, and P. Robel Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids Proc Natl Acad Sci USA 95 1998 4089 4091
52. E. Friess, L. Trachsel, J. Guldner, T. Schier, A. Steiger, and F. Holsboer DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range Am J Physiol 268 Endocrinol Metab 31 1995 E107 E113
53. T. Hillen, A. Lun, F.M. Reischies, M. Borchelt, E. Steinhagen-Thiessen, and R.T. Schaub DHEA-S plasma levels and incidence of Alzheimer's disease Biol Psychiatry 47 2000 161 163
54. M. Bloch, P.J. Schmidt, M.A. Danaceau, L.F. Adams, and D.R. Rubinow Dehydroepiandrosterone treatment of midlife dysthymia Biol Psychiatry 45 1999 1533 1541
55. O.M. Wolkowitz, V.I. Reus, E. Roberts, F. Manfredi, T. Chan, and W.J. Raum Dehydroepiandrosterone (DHEA) treatment of depression Biol Psychiatry 41 1997 311 318
56. W. Arlt, F. Callies, I. Koehler, J.C. van Vlijmen, M. Fassnacht, and C.J. Strasburger Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion J Clin Endocrinol Metab 86 2001 4686 4692
57. J.G. Rabkin, S.J. Ferrando, G.J. Wagner, and R. Rabkin DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters Psychoneuroendocrinology 25 2000 53 68
58. R.D. Strous, R. Maayan, R. Lapidus, R. Stryjer, M. Lustig, and M. Kotler Deydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia Arch Gen Psychiatry 60 2003 133 141
59. P.J. Schmidt, R.C. Daly, M. Bloch, M.J. Smith, M.A. Danaceau, and L.S. St Clair Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression Arch Gen Psychiatry 62 2005 154 162
60. O. Khorram, L. Vu, and S.S.C. Yen Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men J Gerontol: Med Sci 52A 1997 M1 M7
61. Yen SSC, A.J. Morales, and O. Khorram Replacement of DHEA in aging men and women. Potential Remedial Effects Ann NY Acad Sci 774 1995 128 142
62. S.B. Solerte, R. Gornati, L. Cravello, N. Albertelli, S. Oberti, and D. Perotta Dehydroepiandrosterone-sulfate (DHEA-S) restores the release of IGF-1 from natural killer (NK) immune cells in old patients with dementia of Alzheimer's type (DAT) J Endocrinol Invest 22 Suppl 10 1999 32 34
63. B. Araneo, T. Dowell, M.L. Woods, R. Daynes, M. Judd, and T. Evans DHEAS as an effective vaccine adjuvant in elderly humans Ann NY Acad Sci 774 1995 232 248
64. H.D. Danenberg, A. Ben-Yehuda, Z. Zakay-Rones, D.J. Gross, and G. Friedman Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects J Clin Endocrinol Metab 82 1997 2911 2914
65. T. Andus, F. Klebl, G. Rogler, N. Bregenzer, J. Schölmerich, and R.H. Straub Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study Aliment Pharmacol Ther 17 2003 409 414
66. B. De la Torre, M. Hedman, and R. Befrits Blood and tissue dehydroepiandrosterone sulphate levels and their relationship to chronic inflammatory bowel disease Clin Exp Rheumatol 16 1998 579 582
67. M. Maggio, G.P. Ceda, L. Denti, I. Rebecchi, P. Manganelli, and F. Ablondi Decreased DHEAS secretion in patients with chronic inflammatory diseases treated with glucocorticoids J Endocrinol Invest 25 Suppl 10 2002 87 88
68. R. van Vollenhoven, E.G. Engleman, and J.L. McGuire An open study of dehydroepiandrosterone in systemic lupus erythematosus Arthritis & Rheumatism 37 1994 1305 1310
69. M.A. Petri, P.J. Mease, J.T. Merrill, R.G. Lahita, M.J. Iannini, and D.E. Yocum Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus Arthritis Rheum 50 2004 2858 2868
70. J.T. Merrill Dehydroepiandrosterone, a sex steroid metabolite in development for systemic lupus erythematosus Expert Opin Investig Drugs 12 2003 1017 1025
71. J. Young, B. Couzinet, K. Nahoul, S. Brailly, P. Chanson, and E.E. Baulieu Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans J Clin Endocrinol Metab 82 1997 2578 2785
72. 1-24 Clin Endocrinol 55 2001 259 265
73. W. Arlt, J. Haas, F. Callies, M. Reincke, D. Hübler, and M. Oettel Biotransformation of oral dehydroepiandrosterone in elderly men. Significant increase in circulating estrogens J Clin Endocrinol Metab 84 1999 2170 2176
74. D. Liu, and J.S. Dillon Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor Steroids 69 2004 279 289
75. T. Simoncini, P. Mannella, L. Fornari, G. Varone, A. Caruso, and A.R. Genazzani Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms Endocrinol 144 2003 3449 3455
76. R.L. Jesse, K. Loesser, D.M. Eich, Y.Z. Qian, M.L. Hess, and J.E. Nestler Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo Ann NY Acad Sci 774 1995 281 290
77. M. Araghiniknam, S. Chung, T. Nelson-White, C. Eskelson, and R.R. Watson Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans Life Sci 59 1996 147 157
78. A. Khalil, J.P. Fortin, J.G. LeHoux, and T. Fülöp Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation J Lipid Res 41 2000 1552 1561
79. M. Suzuki, L.S. Wright, P. Marwah, J.A. Lardy, and C.N. Svendsen Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex Proc Nat Acad Sci 101 2004 3202 3207
80. N. Orentreich, J.L. Brind, R.L. Rizer, and J.H. Vogelman Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood J Clin Endocrinol Metab 59 1984 551 555
81. B.E. Nordin, R.G. Crilly, D.H. Marshall, and S.A. Barkworth Oestrogens, the menopause and the adrenopause J Endocrinol 89 Suppl 1981 131P 143P
82. K. Carlstrom, S. Brody, N.O. Lunell, A. Lagrelius, G. Mollerstrom, and A. Pousette Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum: differences related to age and sex Maturitas 10 1988 297 306
83. S. Legrain, C. Berr, N. Frenoy, V. Gourlet, B. Debuire, and E.E. Baulieu Dehydroepiandrosterone sulfate in a long-term care aged population Gerontology 41 1995 343 351
84. J. Sulcova, M. Hill, R. Hampl, and L. Starka Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects J Endocrinol 154 1997 57 62
85. F. Labrie, A. Belanger, L. Cusan, J.L. Gomez, and B. Candas Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging J Clin Endocrinol Metab 82 1997 2396 2402
86. G.A. Laughlin, and E. Barrett-Connor Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study J Clin Endocrinol Metab 85 2000 3561 3568
87. H.A. Feldman, C. Longcope, C.A. Derby, C.B. Johannes, A.B. Araujo, and A.D. Coviello Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study J Clin Endocrinol Metab 87 2002 589 598
88. H.G. Burger, E.C. Dudley, J. Cui, L. Dennerstein, and J.L. Hopper A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition J Clin Endocrinol Metab 85 2000 2832 2838
89. T.B. Hargreave, E.J. Meuleman, and W. Weidner Hormonal replacement therapy for aging men? The debate goes on Eur Urol 46 2004 155 161
90. X.H. Zhang, A. Morelli, M. Luconi, L. Vignozzi, S. Filippi, and M. Marini Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum Eur Urol 47 2005 409 416
91. T. Ebert, F. Jockenhovel, A. Morales, and R. Shabsigh The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel Eur Urol 47 2005 137 146
92. A. Aversa, A.M. Isidori, E.A. Greco, E. Giannetta, D. Gianfrilli, and E. Spera Hormonal supplementation and erectile dysfunction Eur Urol 45 2004 535 538
93. C.M. Gordon, E. Grace, S.J. Emans, H.A. Feldman, E. Goodman, and K.A. Becker Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial J Clin Endocrinol Metab 87 2002 4935 4941